• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of 5-fluorouracil infusions in the rat: comparison with man and other species.

作者信息

Collins J M

出版信息

Cancer Chemother Pharmacol. 1985;14(2):108-11. doi: 10.1007/BF00434346.

DOI:10.1007/BF00434346
PMID:3918800
Abstract

Saturable elimination of 5-FU is exhibited in rats during constant infusions. Over the range of 3-480 mg/m2/h, total-body clearance of 5-FU decreases from 600 ml/min/m2 to less than 90 ml/min/m2. Previously published values for catabolism of 5-FU by rat hepatocytes can be used to simulate the plasma concentrations of 5-FU that were measured over this range of infusions. The qualitative pattern of nonlinear pharmacokinetics for 5-FU is similar in rats, dogs, monkeys, and humans. However, there are major quantitative differences in total-body clearance values, expressed in terms of surface area (ml/min/m2) or as a fraction of cardiac output. Rat and monkey have substantially lower 5-FU clearance values than dog and man. Although 5-FU clearance values were similar in dogs and humans, total body clearance values for thymidine are 18-fold higher in humans than in dogs. The selection of an appropriate animal model to pursue the clinical observations of high total body clearance of pyrimidines remains uncertain.

摘要

相似文献

1
Pharmacokinetics of 5-fluorouracil infusions in the rat: comparison with man and other species.
Cancer Chemother Pharmacol. 1985;14(2):108-11. doi: 10.1007/BF00434346.
2
A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients.癌症患者体内5-氟尿嘧啶及其代谢物动力学的数学模型。
Cancer Chemother Pharmacol. 1991;28(2):123-9. doi: 10.1007/BF00689701.
3
Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer.结直肠癌患者全血、血浆和红细胞中5-氟尿嘧啶药代动力学的比较。
Pharmacotherapy. 1997 Sep-Oct;17(5):881-6.
4
Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats.结直肠癌中5-氟尿嘧啶合成代谢的动力学模型:大鼠正电子发射断层扫描研究
Cancer Res. 2003 Jul 1;63(13):3667-74.
5
Salivary excretion of 5-fluorouracil (5-FU). IV. Dependency of saliva/plasma concentration ratio and salivary clearance on plasma concentration of 5-FU during constant-rate intravenous infusion in rats.5-氟尿嘧啶(5-FU)的唾液排泄。IV. 大鼠恒速静脉输注期间唾液/血浆浓度比和唾液清除率对5-FU血浆浓度的依赖性。
J Pharmacobiodyn. 1989 Mar;12(3):137-44. doi: 10.1248/bpb1978.12.137.
6
Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer.转移性结直肠癌患者中5-氟尿嘧啶群体药代动力学的昼夜节律
Cancer Chemother Pharmacol. 1999;44(4):295-302. doi: 10.1007/s002800050980.
7
5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs.
Biochem Pharmacol. 1994 Jul 19;48(2):233-6. doi: 10.1016/0006-2952(94)90092-2.
8
Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.茚地那韦(一种有效的人类免疫缺陷病毒蛋白酶抑制剂)在药代动力学和代谢方面的种属差异。
Drug Metab Dispos. 1996 Oct;24(10):1111-20.
9
Salivary excretion of 5-fluorouracil. II. Fluctuation of saliva/plasma concentration ratio and salivary clearance during a constant rate intravenous infusion in beagle dogs.5-氟尿嘧啶的唾液排泄。II. 比格犬恒速静脉输注过程中唾液/血浆浓度比及唾液清除率的波动
J Pharmacobiodyn. 1988 Jun;11(6):438-43. doi: 10.1248/bpb1978.11.438.
10
Conversion of a novel 5-fluorouracil (5-FU) derivative to 5-FU in rats.一种新型5-氟尿嘧啶(5-FU)衍生物在大鼠体内向5-FU的转化。
Res Commun Chem Pathol Pharmacol. 1983 Apr;40(1):99-108.

引用本文的文献

1
Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma.与血浆相比,5-氟尿嘧啶在人和鼠肿瘤中高浓度的持续保留。
Cancer Chemother Pharmacol. 1993;31(4):269-76. doi: 10.1007/BF00685670.
2
Modulation of tumor cell response to chemotherapy by the organ environment.器官环境对肿瘤细胞化疗反应的调节作用。
Cancer Metastasis Rev. 1994 Jun;13(2):209-22. doi: 10.1007/BF00689637.
3
Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.

本文引用的文献

1
THE PHYSIOLOGIC DISPOSITION OF 5-FLUOROURACIL AND 5-FLUORO-2'-DEOXYURIDINE IN MAN.
Clin Pharmacol Ther. 1964 Sep-Oct;5:581-610. doi: 10.1002/cpt196455581.
2
Kinetic studies on the deethylation of ethoxybenzamide. A comparative study with isolated hepatocytes and liver microsomes of rat.乙氧苯酰胺脱乙基作用的动力学研究。大鼠离体肝细胞和肝微粒体的比较研究。
Biochem Pharmacol. 1980 Oct 15;29(20):2825-30. doi: 10.1016/0006-2952(80)90018-0.
3
Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes.人体中5-氟尿嘧啶的非线性药代动力学模型:静脉注射和腹腔注射途径
左旋咪唑/氟尿嘧啶。其药理学及在结直肠癌辅助治疗中的应用综述。
Drugs Aging. 1991 Jul-Aug;1(4):317-37. doi: 10.2165/00002512-199101040-00007.
Clin Pharmacol Ther. 1980 Aug;28(2):235-46. doi: 10.1038/clpt.1980.156.
4
Concentration-dependent disappearance of fluorouracil from peritoneal fluid in the rat: experimental observations and distributed modeling.氟尿嘧啶在大鼠腹膜液中浓度依赖性消失:实验观察与分布建模
J Pharm Sci. 1982 Jul;71(7):735-8. doi: 10.1002/jps.2600710704.
5
Contribution of lungs to total body clearance: linear and nonlinear effects.肺对全身清除率的贡献:线性和非线性效应。
J Pharm Sci. 1982 Jan;71(1):66-70. doi: 10.1002/jps.2600710117.
6
Nonlinear pharmacokinetics of thymidine, thymine, and fluorouracil and their kinetic interactions in normal dogs.正常犬体内胸苷、胸腺嘧啶和氟尿嘧啶的非线性药代动力学及其动力学相互作用
Cancer Res. 1983 Oct;43(10):4587-95.
7
Pulmonary transit time and diffusing capacity in mammals.
Am J Physiol. 1984 Mar;246(3 Pt 2):R384-8. doi: 10.1152/ajpregu.1984.246.3.R384.
8
Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey.
Cancer Res. 1984 Nov;44(11):4929-32.
9
Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.大鼠体内5-氟尿嘧啶和5'-脱氧-5-氟尿苷的药代动力学研究
J Pharmacol Exp Ther. 1983 Oct;227(1):174-80.
10
The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man.5-氟胞嘧啶-2-¹⁴C和胞嘧啶-¹⁴C在大鼠体内的代谢以及5-氟胞嘧啶-2-¹⁴C在人体内的分布。
Biochem Pharmacol. 1966 Apr;15(4):435-46. doi: 10.1016/0006-2952(66)90254-1.